Rankings
▼
Calendar
NVAX Q2 2016 Earnings — Novavax, Inc. Revenue & Financial Results | Market Cap Arena
NVAX
Novavax, Inc.
$2B
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
Gross Profit
$3M
100.0% margin
Operating Income
-$76M
-3053.8% margin
Net Income
-$79M
-3167.7% margin
EPS (Diluted)
$-5.86
QoQ Revenue Growth
-40.6%
Cash Flow
Operating Cash Flow
-$62M
Free Cash Flow
-$68M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$525M
Total Liabilities
$415M
Stockholders' Equity
$110M
Cash & Equivalents
$89M
← FY 2016
All Quarters
Q3 2016 →